Diagon

Executive Summary

Diagon is a privately-held Hungarian diagnostics company founded in 1989, headquartered in Budapest. It is a market leader in providing specialized reagents, controls, and consumables for automated hematology and coagulation analyzers, offering compatible solutions for a wide range of instruments from major global manufacturers. Serving laboratory professionals, Diagon has established a strong niche in the diagnostics space, particularly in Eastern Europe. While the company does not disclose financials or have a public pipeline, its long-standing presence and focus on compatibility with leading analyzers suggest a stable, recurring revenue model. Given its private status and lack of recent news, Diagon appears to be a steady operator with limited near-term catalysts, but its technical expertise and market position could support moderate growth.

Upcoming Catalysts (preview)

• Q4 2026New reagent line for next-generation hematology analyzers60% success
• Q2 2027Expansion into Western European markets via distribution agreements40% success
• Q3 2026Strategic partnership with a major diagnostics OEM30% success